Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 437

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis

Anstey, Kaarin J., Lipnicki, Darren M., Low, Lee-Fay·2008·The American Journal of Geriatric Psychiatry
DOI 10.1097/01.jgp.0000310778.20870.ae
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.jgp.0000310778.20870.ae

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 44

  1. Whalley, 2006, A life-course approach to the aetiology of late-onset dementias, Lancet Neurol, 5, 87, 10.1016/S1474-4422(05)70286-6 · DOI · Paper page
  2. Panza, 2006, Cognitive frailty: predementia syndrome and vascular risk factors, Neurobiol Aging, 27, 933, 10.1016/j.neurobiolaging.2005.05.008 · DOI
  3. Panza, 2006, Lipid metabolism in cognitive decline and dementia, Brain Res Rev, 51, 275, 10.1016/j.brainresrev.2005.11.007 · DOI · Paper page
  4. Launer, 2005, The epidemiologic study of dementia: a life-long quest?, Neurobiol Aging, 26, 335, 10.1016/j.neurobiolaging.2004.03.016 · DOI · Paper page
  5. Kivipelto, 2006, Cholesterol as a risk factor for Alzheimer's disease—epidemiological evidence, Acta Neurol Scand Suppl, 185, 50, 10.1111/j.1600-0404.2006.00685.x · DOI · Paper page
  6. Hofer, 2001, Understanding ageing. An evaluation of research designs for assessing the interdependence of ageing-related changes, Gerontology, 47, 341, 10.1159/000052825 · DOI · Paper page
  7. Qiu, 2005, The age-dependent relation of blood pressure to cognitive function and dementia, Lancet Neurol, 4, 487, 10.1016/S1474-4422(05)70141-1 · DOI · Paper page
  8. Anstey, 2007, Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies, Am J Epidemiol, 166, 367, 10.1093/aje/kwm116 · DOI · Paper page
  9. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  10. Roman, 1993, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250 · DOI · Paper page
  11. Petersen, 1995, Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals, JAMA, 273, 1274, 10.1001/jama.1995.03520400044042 · DOI · Paper page
  12. de Craen, 2005, Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia, Am J Epidemiol, 161, 114, 10.1093/aje/kwi029 · DOI
  13. Bernick, 2005, Statins and cognitive function in the elderly: the Cardiovascular Health Study, Neurology, 65, 1388, 10.1212/01.wnl.0000182897.18229.ec · DOI
  14. Cervilla, 2000, Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project, J Neurol Neurosurg Psychiatry, 68, 622, 10.1136/jnnp.68.5.622 · DOI
  15. Prince, 2000, The association between APOE and dementia does not seem to be mediated by vascular factors, Neurology, 54, 397, 10.1212/WNL.54.2.397 · DOI
  16. Rea, 2005, Statin use and the risk of incident dementia: the Cardiovascular Health Study, Arch Neurol, 62, 1047, 10.1001/archneur.62.7.1047 · DOI · Paper page
  17. Zimetbaum, 1992, Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study, Arterioscler Thromb, 12, 416, 10.1161/01.ATV.12.4.416 · DOI
  18. Moroney, 1999, Low-density lipoprotein cholesterol and the risk of dementia with stroke, JAMA, 282, 254, 10.1001/jama.282.3.254 · DOI · Paper page
  19. Romas, 1999, APOE genotype, plasma lipids, lipoproteins, and AD in community elderly, Neurology, 53, 517, 10.1212/WNL.53.3.517 · DOI · Paper page
  20. Tan, 2003, Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study, Arch Intern Med, 163, 1053, 10.1001/archinte.163.9.1053 · DOI · Paper page
  21. Kivipelto, 2002, Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease, Ann Intern Med, 137, 149, 10.7326/0003-4819-137-3-200208060-00006 · DOI · Paper page
  22. Notkola, 1998, Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease, Neuroepidemiology, 17, 14, 10.1159/000026149 · DOI · Paper page
  23. Stewart, 2007, Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study, Arch Neurol, 64, 103, 10.1001/archneur.64.1.103 · DOI · Paper page
  24. Li, 2005, Serum cholesterol and risk of Alzheimer disease: a community-based cohort study, Neurology, 65, 1045, 10.1212/01.wnl.0000178989.87072.11 · DOI · Paper page
  25. Slooter, 2000, The effect of apoE on dementia is not through atherosclerosis: The Rotterdan Study: Reply, Neurology, 54, 2357
  26. Beeri, 2006, Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers, Neurology, 66, 1399, 10.1212/01.wnl.0000210447.19748.0b · DOI
  27. Kivipelto, 2001, Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study, BMJ, 322, 1447, 10.1136/bmj.322.7300.1447 · DOI · Paper page
  28. Solfrizzi, 2004, Vascular risk factors, incidence of MCI, and rates of progression to dementia, Neurology, 63, 1882, 10.1212/01.WNL.0000144281.38555.E3 · DOI · Paper page
  29. Kalmijn, 1996, Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men, Stroke, 27, 2230, 10.1161/01.STR.27.12.2230 · DOI · Paper page
  30. Reitz, 2005, Impact of plasma lipids and time on memory performance in healthy elderly without dementia, Neurology, 64, 1378, 10.1212/01.WNL.0000158274.31318.3C · DOI
  31. Hyman, 1996, Apolipoprotein E and cognitive change in an elderly population, Ann Neurol, 40, 55, 10.1002/ana.410400111 · DOI · Paper page
  32. Kuusisto, 1997, Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study, BMJ, 315, 1045, 10.1136/bmj.315.7115.1045 · DOI · Paper page
  33. Wada, 1997, Lower serum cholesterol level and later decline in cognitive function in older people living in the community, Japan, J Am Geriatr Soc, 45, 1411, 10.1111/j.1532-5415.1997.tb02949.x · DOI
  34. Swan, 1992, Decline in cognitive performance in aging twins. Heritability and biobehavioral predictors from the National Heart, Lung, and Blood Institute Twin Study, Arch Neurol, 49, 476, 10.1001/archneur.1992.00530290058012 · DOI
  35. Borroni, 2006, APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk, Am J Geriatr Psychiatry, 14, 1022, 10.1097/01.JGP.0000225088.29353.08 · DOI
  36. Solomon, 2007, Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study, Neurology, 68, 751, 10.1212/01.wnl.0000256368.57375.b7 · DOI · Paper page
  37. Chiang, 2007, Midlife risk factors for subtypes of dementia: A Nested Case-Control Study in Taiwan, Am J Geriatr Psychiatry, 15, 762, 10.1097/JGP.0b013e318050c98f · DOI
  38. Monastero, 2007, Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the Kungsholmen Project, Am J Geriatr Psychiatry, 15, 60, 10.1097/01.JGP.0000229667.98607.34 · DOI
  39. Zuliani, 2004, Combined measurement of serum albumin and high-density lipoprotein cholesterol strongly predicts mortality in frail older nursing-home residents, Aging Clin Exp Res, 16, 472, 10.1007/BF03327404 · DOI
  40. Almeida, 2007, Association of cardiovascular risk factors and disease with depression in later life, Am J Geriatr Psychiatry, 15, 506, 10.1097/01.JGP.0000246869.49892.77 · DOI
  41. Jick, 2000, Statins and the risk of dementia, Lancet, 356, 1627, 10.1016/S0140-6736(00)03155-X · DOI · Paper page
  42. Shea, 2007, Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews, BMC Med Res Methodol, 7, 10, 10.1186/1471-2288-7-10 · DOI · Paper page
  43. Karlamangla, 2004, Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur studies of successful aging.[see comment], J Am Geriatr Soc, 52, 487, 10.1111/j.1532-5415.2004.52152.x · DOI
  44. Kivipelto, 2001, Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study, Neurology, 56, 1683, 10.1212/WNL.56.12.1683 · DOI · Paper page

Cited by

See all 437

Metadata

Authors
Anstey, K. J., Lipnicki, D. M., & Low, L.-F.
Venue
The American Journal of Geriatric Psychiatry
Publisher
Elsevier BV
Published
2008-05
Volume
16
Issue
5
Pages
343-354
ISSN
1064-7481 (ISSN-L)
DOI
10.1097/01.jgp.0000310778.20870.ae
OpenAlex
W2103000829
Cited by
437
References
7
FWCI
3.42
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis. https://app.cochat.ai/papers/10.1097/01.jgp.0000310778.20870.ae
The paper
Anstey, K. J., Lipnicki, D. M., & Low, L.-F. (2008). Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis. The American Journal of Geriatric Psychiatry. https://doi.org/10.1097/01.jgp.0000310778.20870.ae

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.